Literature DB >> 24902690

D-shape asymmetric excision of sacrococcygeal pilonidal sinus with primary closure, suction drain, and subcuticular skin closure: an analysis of risks factors for long-term recurrence.

Luigi Brusciano1, Paolo Limongelli2, Gianmattia Del Genio2, Salvatore Tolone2, Vincenzo Amoroso2, Giovanni Docimo2, Ludovico Docimo2.   

Abstract

BACKGROUND: Few studies have reported long-term recurrence rates after asymmetric excision with primary closure in the treatment of sacrococcygeal pilonidal disease.
METHODS: A retrospective analysis of a prospectively maintained database of 550 surgical excisions performed for sacrococcygeal pilonidal disease between 1988 and 2005 was performed.
RESULTS: A total of 550 patients with a diagnosis of pilonidal sinus underwent surgical excision over a period of 17 years. Thirty-eight out of the 550 patients (3.5%) were lost at follow-up. At a mean follow up of 11.2 ± 5.3 years, median 11 years (range = 3-22), the recurrence rate was 8.9%. Actuarial 1-, 5-, 10-, and 20-year disease-free survival rates were 98%, 94%, 92%, and 83%, respectively, with a median overall disease-free survival of 10 years (95% confidence interval [CI] = 3-15). When patients were stratified according to several variables known to influence recurrence, an age of less or ≥22 years (odds ratio [OR] = 1.5, 95% CI = 0.3-7.5, P = .001), a family history of sinus (OR = 5.9, 95% CI = 2.7-12, P = .0001), and intraoperative methylene blue use (OR = 6.3, 95% CI = 1.2-31, P = .024) were indicated as independent predictors of disease-free survival rates.
CONCLUSIONS: D-shape asymmetric excision and scar lateralization, with primary multilayer subcuticular closure, suction drain insertion, and skin closure in patients with sacrococcygeal pilonidal disease is a safe and adequate surgical treatment offering an effective healing rate as well as low recurrence. Several features are likely to predict a better or a worse long-term recurrence rate in patients undergoing surgery for sinus pilonidalis.
© The Author(s) 2014.

Entities:  

Keywords:  asymmetric excision; colorectal surgery; surgical treatment sinus

Mesh:

Year:  2014        PMID: 24902690     DOI: 10.1177/1553350614535856

Source DB:  PubMed          Journal:  Surg Innov        ISSN: 1553-3506            Impact factor:   2.058


  6 in total

1.  The treatment of pilonidal disease: guidelines of the Italian Society of Colorectal Surgery (SICCR).

Authors:  D Segre; M Pozzo; R Perinotti; B Roche
Journal:  Tech Coloproctol       Date:  2015-09-16       Impact factor: 3.781

2.  D-shape asymmetric excision in recurrent pilonidalis disease: an analytic longitudinal long-term evaluation.

Authors:  Luigi Brusciano; Gianmattia Del Genio; Salvatore Tolone; Michele Schiano di Visconte; Giorgia Gualtieri; Gianmattia Terracciano; Claudio Gambardella; Ludovico Docimo
Journal:  Updates Surg       Date:  2019-03-18

3.  Common surgical procedures in pilonidal sinus disease: A meta-analysis, merged data analysis, and comprehensive study on recurrence.

Authors:  V K Stauffer; M M Luedi; P Kauf; M Schmid; M Diekmann; K Wieferich; B Schnüriger; D Doll
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

4.  Impact of geography and surgical approach on recurrence in global pilonidal sinus disease.

Authors:  Dietrich Doll; Andriu Orlik; Katharina Maier; Peter Kauf; Marco Schmid; Maja Diekmann; Andreas P Vogt; Verena K Stauffer; Markus M Luedi
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

5.  Inverse 'D' incision technique in treatment of pilonidal sinus disease; excision with minimal tissue loss, closure without tension and lateral location of the suture line.

Authors:  Sami Dogan; Fuat Cetin; Emin Gurleyik
Journal:  Ann Surg Treat Res       Date:  2019-11-01       Impact factor: 1.859

6.  Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of pilonidal disease.

Authors:  R Perinotti; G Gallo; M Milone; L Basso; M Manigrasso; R Pietroletti; A Bondurri; M La Torre; G Milito; M Pozzo; D Segre
Journal:  Tech Coloproctol       Date:  2021-06-27       Impact factor: 3.781

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.